Last reviewed · How we verify
Deficiency of mevalonate kinase
Approved treatments
- Ilaris · Novartis Pharms
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Deficiency of mevalonate kinase patent landscape — cliff calendar, originator estates, attackable patents
- Deficiency of mevalonate kinase treatment landscape brief
- Deficiency of mevalonate kinase treatment updates RSS
Frequently asked questions about Deficiency of mevalonate kinase
What drugs treat Deficiency of mevalonate kinase?
Tracked treatments include Ilaris.
What is the treatment for Deficiency of mevalonate kinase?
Standard treatment for Deficiency of mevalonate kinase includes Ilaris. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Deficiency of mevalonate kinase patent cliff · Deficiency of mevalonate kinase CI report
- Treatment: Ilaris · Novartis Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing